Results are more pronounced and longer lasting compared to topical estriol treatment.
Wausau, WI (May 9, 2017) – Research conducted by Adrian Gaspar, MD; Hugo Brandi, PhD, ME; Valentin Gomez, MD; and Daniel Luque, MD was selected as Editor’s Choice in the February 2017 issue of Lasers in Surgery and Medicine (LSM).
The manuscript titled, “Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause” was published in LSM, the official journal of the American Society for Laser Medicine and Surgery, Inc. (ASLMS).
An estimated 10-45 percent of postmenopausal women suffer from vulvovaginal atrophy, leading to a significant effect on their sexual health and quality of life.
“The purpose of this paper is to demonstrate how we can correct the symptoms of vaginal atrophy and reverse this condition in a less aggressive manner without the necessity of ablation. At the same time, there is a positive therapeutic effect, both in duration and quality of results, compared with the use of topical estriol on the vaginal mucosa. Once again, research has opened a new challenge for the laser enthusiast in gynecology regarding anti-aging of the mucosa, the concept of which was first introduced almost 10 years ago by this same author,” stated Dr. Gaspar.
Adrian Gaspar is an obstetrician-gynecologist from Argentina who has dedicated himself to research and teaching in addition to clinical practice. He has developed related technologies for various companies and has been collaborating with various universities around the world over the last 15 years in the area of research and teaching. He is a member of a long list of international scientific societies, as well as a founding member of the Argentine Society of Esthetic Gynecology (SARGE). Doctor Gaspar published the first paper related to Laser Vaginal Rejuvenation in 2011 in the American Journal of Cosmetic Surgery with the Gynecology Department of Mendoza University in Argentina. He was recently given an award of distinction by the European Society of Aesthetic Gynecology (ESAG) because of his innovative development of the intra-urethral laser procedure for the treatment of female urinary incontinence.
Editor’s Choice is an exclusive article published in LSM, the official journal of the ASLMS. View the complete manuscript.
The American Society for Laser Medicine and Surgery, Inc. (ASLMS) is the largest multi-disciplinary professional organization, dedicated to the development and application of lasers and related technology for health care applications. ASLMS promotes excellence in patient care by advancing biomedical application of lasers and other related technologies worldwide. Currently, ASLMS has over 4,000 members, including physicians and surgeons representing more than 51 specialties, physicists involved in product development, biomedical engineers, biologists, nurses, industry representatives and manufacturers.